Table 4 Multivariate analysis of overall survival in patients with renal cell carcinoma.
From: Lower mean platelet volume predicts poor prognosis in renal cell carcinoma
Hazard ratio | 95% CI | P-value | |
|---|---|---|---|
Age (years) (≥60 versus <60) | 1.155 | 0.739–1.804 | 0.528 |
Hemoglobin (g/dl) | 0.986 | 0.977–0.996 | 0.006 |
Platelet count (×109/L) | 1.003 | 1.001–1.006 | 0.005 |
MPV (fL) (≤7.5 versus >7.5) | 1.758 | 1.083–2.855 | 0.023 |
Tumor size (cm) | |||
(>4.0 versus ≤4.0) | 1.867 | 1.134–3.075 | 0.014 |
T classification | |||
(T3+T4 versus T1+T2) | 0.788 | 0.320–1.942 | 0.605 |
Lymph node metastasis | |||
(Present versus Absent) | 2.539 | 1.299–4.961 | 0.006 |
Distant metastasis | |||
(Present versus Absent) | 0.595 | 0.252–1.404 | 0.236 |
Microvascular invasion | |||
(Present versus Absent) | 1.193 | 0.649–2.190 | 0.570 |
TNM stage | |||
(III/IV versus I/II) | 4.034 | 1.911–8.516 | <0.001 |